These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33836552)

  • 1. The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
    Tatoglu MT; Uslu H; Ibisoglu E
    Nuklearmedizin; 2021 Oct; 60(5):381-382. PubMed ID: 33836552
    [No Abstract]   [Full Text] [Related]  

  • 2. [
    Fernando A; Pattison J; Horsfield C; D'Cruz D; Cook G; O'Brien T
    Eur Urol; 2017 Jun; 71(6):926-933. PubMed ID: 27876167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
    Pipitone N; Versari A; Vaglio A; Salvarani C
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Accorsi Buttini E; Maritati F; Vaglio A
    Eur Urol; 2018 Jan; 73(1):145-146. PubMed ID: 29033102
    [No Abstract]   [Full Text] [Related]  

  • 6. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.
    Bertagna F; Treglia G; Leccisotti L; Bosio G; Motta F; Giordano A; Giubbini R
    Jpn J Radiol; 2012 Jun; 30(5):415-21. PubMed ID: 22421932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography in a case of retroperitoneal fibrosis.
    Sakamoto A; Okamoto K; Ishizaka N; Tejima K; Hirata Y; Nagai R
    Int Heart J; 2006 Jul; 47(4):645-50. PubMed ID: 16960419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
    Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
    Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [
    Moreau A; Giraudet AL; Mognetti T; Kryza D
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1758-1759. PubMed ID: 31093709
    [No Abstract]   [Full Text] [Related]  

  • 10. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
    Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
    Young PM; Peterson JJ; Calamia KT
    Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
    Moroni G; Castellani M; Balzani A; Dore R; Bonelli N; Longhi S; Martinelli I; Messa P; Gerundini P
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1635-42. PubMed ID: 22801728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review.
    Treglia G; Mattoli MV; Bertagna F; Giubbini R; Giordano A
    Rheumatol Int; 2013 Mar; 33(3):549-55. PubMed ID: 23124736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG).
    Kotani S; Wakamatsu R; Itoh A; Miyamoto K; Yoshino M; Takami K; Ishihara S; Miura N; Banno S; Imai H
    Intern Med; 2012; 51(7):755-8. PubMed ID: 22466833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Hanssen O; Lovinfosse P; Weekers L; Hustinx R; Jouret F
    Nephrol Ther; 2019 Nov; 15(6):430-438. PubMed ID: 30982747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis.
    Vaglio A; Versari A; Fraternali A; Ferrozzi F; Salvarani C; Buzio C
    Arthritis Rheum; 2005 Feb; 53(1):122-5. PubMed ID: 15696564
    [No Abstract]   [Full Text] [Related]  

  • 17. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
    Nemec P; Rehák Z; Fabián P; Soucek M
    Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
    Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
    J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of
    Wang Y; Guan Z; Gao D; Luo G; Li K; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhang J; Zhu J; Huang F
    Semin Arthritis Rheum; 2018 Feb; 47(4):593-600. PubMed ID: 28958769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.